Influence of prior ACE inhibitor therapy on morbidity and mortality following acute myocardial infarction. - Wikidata - wikimedia - TriplyDB

Influence of prior ACE inhibitor therapy on morbidity and mortality following acute myocardial infarction.

Influence of prior ACE inhibitor therapy on morbidity and mortality following acute myocardial infarction.

http://www.wikidata.org/entity/Q30472861

about

Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction.

P2860

Q36370540-13790B69-222D-471F-9D2C-ABAB3EEA1902

P2860

Influence of prior ACE inhibitor therapy on morbidity and mortality following acute myocardial infarction.

http://www.wikidata.org/entity/Q30472861

description

1998 nî lūn-bûn

@nan

1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Influence of prior ACE inhibit ...... g acute myocardial infarction.

@ast

Influence of prior ACE inhibit ...... g acute myocardial infarction.

@en

type

label

Influence of prior ACE inhibit ...... g acute myocardial infarction.

@ast

Influence of prior ACE inhibit ...... g acute myocardial infarction.

@en

prefLabel

Influence of prior ACE inhibit ...... g acute myocardial infarction.

@ast

Influence of prior ACE inhibit ...... g acute myocardial infarction.

@en

P1433

Q30472861-53A244D9-138C-4481-8B0C-DD64DBD7FAA6

P1476

Q30472861-2964090F-048B-468B-B8F5-A7520D0F7DF0

P2093

Q30472861-0CECA3A6-EC37-4444-B18F-C9EE98722239

Q30472861-248798F7-7133-4302-9B48-3EB4A1DEC190

Q30472861-57B50EC0-AFA8-494F-9400-F3BC931A54C6

Q30472861-57D0C57B-985D-43CE-84BB-42E9F465A230

Q30472861-7C002D85-26EC-4B4D-82AF-F39DACBFB6EE

Q30472861-F5ED6D5A-93D3-4F4B-BC22-93977441C894

Q30472861-FD5DE227-2472-4E87-9726-41DAA64777A8

P2860

Q30472861-0521C5D7-66ED-46AA-A35D-7BC87B38FECF

Q30472861-0F14E04B-4EC9-4544-AEF6-E9F6FA929AA7

Q30472861-30AC1161-2FC9-4996-8FC6-27B2842A4277

Q30472861-45A26D09-53AB-415E-844F-7811EB8FBFF6

Q30472861-5C32DD53-F743-4B8A-8334-41217076A624

Q30472861-626310C6-F83C-45E8-AF3D-7B70A54CB775

Q30472861-6EA3CC85-9630-4818-A22C-182439E33046

Q30472861-6FA517C7-124E-4C7F-BC7E-32062B163582

Q30472861-73EF6606-0D0A-4962-A35F-CDAC26DAEDB4

Q30472861-8861C3BE-F671-4C6A-AA92-968DA036A849

P304

Q30472861-89937EB3-8602-47E0-ACBD-8DC7E6266197

P31

Q30472861-BC691737-B5B8-4D57-8771-E56C9354F40A

P356

Q30472861-2E6536B0-3208-49BC-AC2E-DA1A0A35BEEA

P407

Q30472861-826BDDB6-EC6F-42AA-81CD-9BA848EC85F8

P433

Q30472861-3C5A0F50-39CE-4046-A1D2-076737079DDF

P478

Q30472861-D80AC7F1-6C17-4C37-8518-CF967208C5D2

P577

Q30472861-DAF9083B-7694-465E-BD7B-085F74A5187E

P698

Q30472861-DAD3D6AA-0990-4D85-8B2D-B036F276E88E

P921

Q30472861-55DCBC42-D7EA-49BD-832F-8A83C8A45789

P356

P1433

Annals of Pharmacotherapy

P1476

Influence of prior ACE inhibit ...... g acute myocardial infarction.

@en

P2093

B Cooil

http://www.w3.org/2001/XMLSchema#string

D C Russell

http://www.w3.org/2001/XMLSchema#string

M Boyne

http://www.w3.org/2001/XMLSchema#string

N R Dickson

http://www.w3.org/2001/XMLSchema#string

N Wattanasuwan

http://www.w3.org/2001/XMLSchema#string

P Raggi

http://www.w3.org/2001/XMLSchema#string

R Pereira

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Myocardial ischemia, reperfusion and free radical injury.

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

Neuroendocrine activation in acute myocardial infarction.

Neurohumoral activation during acute myocardial ischaemia. Effects of ACE inhibition.

Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.

ACE inhibitors for myocardial infarction: how should they be used?

P304

1141-1146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.18071

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9825077

http://www.w3.org/2001/XMLSchema#string

P921